J&J's real-world bladder cancer study started in HealthVerity Marketplace
High-risk NMIBC: Disease overview and treatment approach Johnson & Johnson quickly identified and...
High-risk NMIBC: Disease overview and treatment approach Johnson & Johnson quickly identified and...
The one constant in healthcare marketing is change, particularly in four key areas: Evolving...
Our series exploring the value of real-world data (RWD) throughout the pharmaceutical product life...
Historically, pharmaceutical manufacturers leveraged retail pharmacy prescriptions to identify...
With the start of 2024, we are moving toward a world without third-party cookies to track consumer...
Healthcare brand marketing is at a crossroads. With patients taking a more active role in their...
As therapies become increasingly complex and personalized, it is imperative that physicians...
High-risk NMIBC: Disease overview and treatment approach Johnson & Johnson quickly identified and analyzed a high-risk non–muscle invasive bladder cancer (HR-NMIBC) population using HealthVerity Marketplace. By using linked, privacy-compliant cla...